• LAST PRICE
    1.0400
  • TODAY'S CHANGE (%)
    Trending Up0.0700 (7.2165%)
  • Bid / Lots
    1.0400/ 13
  • Ask / Lots
    1.0500/ 18
  • Open / Previous Close
    1.0000 / 0.9700
  • Day Range
    Low 0.9900
    High 1.1000
  • 52 Week Range
    Low 0.5509
    High 1.4500
  • Volume
    179,389
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.97
TimeVolumeONTX
09:32 ET5000.9901
09:34 ET131291.0049
09:38 ET2481
09:41 ET1001.01
09:43 ET24991.02
09:50 ET74221.0105
09:56 ET19731.04
09:57 ET44311.03
09:59 ET8001.0205
10:01 ET25001.021
10:03 ET3501.03
10:08 ET21501.02
10:10 ET17301.0369
10:12 ET52871.06
10:14 ET210921.05
10:15 ET4001.05
10:17 ET196201.0699
10:19 ET23841.085
10:21 ET34601.0971
10:24 ET14241.085
10:26 ET42151.05
10:33 ET22051.0501
10:35 ET35951.0783
10:37 ET9501.045
10:42 ET6001.05
10:44 ET80501.04
10:51 ET40751.04
10:55 ET20001.055
10:57 ET3001.0616
11:04 ET11101.0501
11:09 ET2601.0669
11:11 ET1251.06
11:13 ET3301.05
11:29 ET48001.05
11:38 ET3501.05
11:40 ET20081.05
11:42 ET5001.05
11:44 ET16001.04
11:47 ET7351.02
11:51 ET1471.0378
11:54 ET16741.0101
12:00 ET54891.01
12:05 ET13881.02
12:07 ET1001.02
12:09 ET192321.05
12:12 ET45991.0574
12:16 ET2481.06
12:18 ET1001.0582
12:21 ET10001.058
12:25 ET20001.05
12:27 ET5001.0501
12:30 ET19001.0502
12:56 ET4001.05
12:57 ET4001.0358
01:15 ET3401.05
01:17 ET10001.0485
01:19 ET1001.045
01:24 ET2001.04
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesONTX
Onconova Therapeutics Inc
20.4M
-1.1x
---
United StatesCLDI
Calidi Biotherapeutics Inc
20.2M
-0.9x
---
United StatesNCNA
NuCana PLC
16.2M
-0.4x
---
United StatesIMUC
Eom Pharmaceutical Holdings Inc
20.7M
-6.2x
---
United StatesAIM
AIM ImmunoTech Inc
21.6M
-1.1x
---
United StatesNRBO
NeuroBo Pharmaceuticals Inc
21.1M
-0.6x
---
As of 2024-03-28

Company Information

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on discovering and developing products for patients with cancer. It has molecularly targeted agents designed to disrupt specific cellular pathways for cancer cell proliferation. It has the two clinical-stage programs: narazaciclib (ON 123300), which is a multi-targeted kinase inhibitor in solid tumors and hematological malignancies as a single agent or in combination with other anti-cancer therapies; and rigosertib administered alone or in combination for the treatment of solid tumors. Narazaciclib targets cyclin-dependent kinases (CDK's), AMPK related protein kinase 5 (ARK5), and colony-stimulating factor 1 receptor (CSF1R) at low nM concentrations as well as other tyrosine kinases. It is also engaged in supporting investigator-initiated studies (IIS) that explores the use of rigosertib for cancers driven by mutated K-Ras genes, including a Phase I/IIa study of rigosertib with a PD-1 inhibitor.

Contact Information

Headquarters
375 Pheasant RunNEWTOWN, PA, United States 18940
Phone
267-759-3681
Fax
267-759-3681

Executives

Independent Chairman of the Board
James Marino
President, Chief Executive Officer, Director
Steven Fruchtman
Chief Financial Officer, Chief Operating Officer
Mark Guerin
Chief Medical Officer
Victor Moyo
Senior Director and Head of Corporate Development
Adar Silverstein

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$20.4M
Revenue (TTM)
$226.0K
Shares Outstanding
21.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.37
EPS
$-0.96
Book Value
$1.35
P/E Ratio
-1.1x
Price/Sales (TTM)
90.1
Price/Cash Flow (TTM)
---
Operating Margin
-9,544.25%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.